Hexamidine diisethionate (HEX D) has been used for its biocidal actions in topical preparations since the 1950s. Recent data also suggest that it plays a beneficial role in skin homeostasis. To date, the extent to which this compound penetrates the epidermis has not been reported nor how its topical delivery may be where there are minor differences in molecular structures. We also believe that they underline the ongoing necessity for fundamental studies on the interaction of topical excipients with the skin.
Introduction
Hexamidine diisethionate (HEX D) has been used as a biocide in topical preparations since 1950 (Robin, 1978) but recent evidence indicates it may have also have a beneficial effect on skin homeostasis. It has been suggested that the inhibitory action of HEX on inflammatory proteases in skin may result in modulation of skin ageing processes (Kimball et al., 2012) . Synthesis of sphingolipid, fatty acid and cholesterol was downregulated in human skin equivalent cell cultures following incubation with HEX D, as was fatty acid and cholesterol uptake; the efflux of cholesterol was also upregulated (Osborne et al., 2009; Jarrold et al., 2010a) . In vivo studies conducted with an emollient containing HEX D and other ingredients have also shown improved skin barrier function compared with controls (Jarrold et al., 2010b) .
Surprisingly the disposition of HEX D in skin has not been examined to date.
In a recent publication (Parisi et al., 2015) we reported the preparation of the dihydrochloride salt (HEX H) as well as the characterisation of both molecules. The rationale for preparation of HEX H was based on its likely more favourable properties for topical delivery compared with HEX D. Effective skin penetration has been observed for molecules with low molecular weights (<500), low melting points and balanced lipophilic -hydrophilic properties (Hadgraft, 2004) . Although HEX H was successfully prepared in the pure form, the melting point of the molecule was higher than that of HEX D. Thermal analysis indicated the melting points of HEX D and HEX H were 225°C and 266°C respectively. Log D values at pH 7.4 were -0.74 for HEX D and -0.70 for HEX H respectively. The investigation of the physicochemical properties of HEX D and HEX H also included determination of UV absorption spectra, pH in aqueous solution, development of appropriate HPLC analytical methods as well as evaluation of solubility and stability in a broad range of solvents and selected binary solvent systems. Following on from these preformulation studies, the aim of the present work was to identify and develop simple formulations to deliver both HEX D and HEX H to the skin.
Because of the excellent barrier properties of the skin, the bioavailability of topically applied active ingredients is generally low. Chemical penetration enhancers (CPEs) are often included in pharmaceutical and cosmetic formulations to improve delivery of actives. Although the precise mechanism of action of most CPEs remains poorly understood, two major effects may be observed when they penetrate the P a g e | 4 stratum corneum (Hadgraft, 1999) . Some CPEs, usually simple solvent type molecules, can alter the skin permeability by increasing the solubility of the permeant in the stratum corneum. Other enhancers may, instead, increase the diffusion coefficient of the permeant by intercalating into the highly organised lipid domain of the stratum corneum and disrupting its packing, thus making it more fluid (Lane, 2013) . Finally, a synergistic effect may be obtained by combining in the same formulation chemical penetration enhancers having different mechanisms of action (Hadgraft, 1999) .
Single solvent systems were selected as the starting point for the development and evaluation of optimal formulations for the topical delivery of HEX D and HEX H. Based on the solubility data for HEX D and HEX H in 19 solvents studied in our previous work (Parisi et al., 2015) , propylene glycol (PG), glycerol and PEG 200
were identified as suitable candidate vehicles. Conducting in-vitro skin permeation studies using diffusion cells is by far the most accepted method used to investigate and screen a series of topical formulations in order to select those which perform better in terms of active ingredient release to the desired target (Franz, 1975;  Organisation for Economic Cooperation and Development, 2004; Hirata et al., 2013) . Permeation studies, however, only allow the quantification of the amount of active which cross the skin barrier. Therefore for this study they are coupled with mass balance studies which provide information on both the amount of active which remains on the skin surface and that which is delivered inside the skin (Tsai et al., 1992; OECD, 2004; Oliveira et al., 2012) . A range of binary systems which combined the single solvents with other CPEs were subsequently prepared and examined. The choice of CPE was based on their miscibility with PG, glycerol and PEG 200 as well as reports in the literature detailing their applications in topical and transdermal delivery (Lane, 2013) .
Materials and Methods

Materials
HEX D (Laboratoires Sérobiologiques, France) was a kind gift from Procter & Gamble (U.K.), while HEX H was synthesized and purified in-house. Porcine ears were obtained from a local abattoir. Propylene glycol (PG), polyethylene glycol 200 (PEG 200) and HPLC grade isopropyl alcohol (IPA) were supplied by Fisher Scientific (U.K.). HPLC grade water, HPLC grade methanol and glycerol were P a g e | 5
provided by Sigma-Aldrich (U.K.). Dimethyl sulfoxide (DMSO) was supplied by VWR International (U.K.). Lauroglycol™ 90 (Propylene glycol monolaurate, PGML) and Transcutol ® P (TC) were received as kind donations from Gattefossé (France). 1,2-pentanediol (1,2-PENT) was provided by Surfachem Group (U.K.).
Dimethyl isosorbide Arlasolve ® (DMI) was supplied by Croda International (U.K.).
Phosphate buffered saline (PBS) (pH = 7.3 ± 0.2 at 25°C) was prepared using Dulbecco A tablets (Oxoid, U.K.). were determined by HPLC (Parisi et al., 2015) . HEX H in the neat solvents was reported in our previous publication and for the binary systems solubility was determined in the same manner (Parisi et al., 2015) . 
Methods
In vitro permeation studies
All permeation studies were conducted using glass vertical Franz diffusion cells and porcine ear skin and followed procedures reported previously (Caon et al., 2010; Oliveira et al., 2012 (Parisi et al., 2015) .
Mass balance studies and validation
At the end of the 48 h permeation studies, the receptor solution was removed from the Franz cells. The donor solution was then withdrawn from each donor compartment and placed in a 10 mL volumetric flask. For hydrophilic solvents HPLC grade water was used for dilution and for hydrophobic solvents DMSO was used. After removing the donor solution, the skin surface was washed twice (each wash consisting of 5 solvent rinses) with HPLC grade water in the case of hydrophilic donor solutions and with DMSO for hydrophobic donor solutions. The
Franz diffusion cells were then disassembled, the skin membranes were placed in centrifuge microtubes and extracted with DMSO:methanol (50:50) on a rotor for 24 h at 32 ± 1°C. Two cycles of sonication (15 min) and centrifugation at 13200 rpm (15 min) were performed in order to complete the extraction. The HEX D and HEX H concentrations in all the diluted donor solutions, washing samples and extraction samples were determined by HPLC (Parisi et al., 2015) . The total active ingredient recovery (%) was then used as an indicator of the reliability of the procedure and values within the range from 80% to 120% were considered acceptable (OECD, 2011).
The mass balance methods were validated using a 0. After removing the donor solution, the skin surface was washed 5 times with HPLC grade water for the PG donor solution, and with DMSO for the PG:PGML solution.
The Franz diffusion cells were then disassembled, the skin membranes were placed in centrifuge microtubes and extracted as described for the mass balance studies.
HEX D and HEX H concentrations in all the diluted donor solution, washing samples and extraction samples were determined by HPLC (Parisi et al., 2015) ; validation required total recovery values of between 95% and 105%.
Data treatment and statistical analysis
The data analysis was performed using Microsoft ® Excel 2010 (Microsoft Corporation, U.S.A.) and OriginPro ® 9.1.0 (OriginLab Corporation, U.S.A.). The data points falling between the LOQ and the LOD were not excluded and were used in the same manner as those above the LOQ (Keizer et al., 2015) . The data below the LOD were instead excluded. As a result, when all the observations constituting a sample were below the LOD, this was reported as not detected (ND). However, when the observations constituting a sample were both above and below the LOD, the latter were statistically estimated in order to be able to calculate meaningful descriptive statistics, such as the sample arithmetic mean, standard deviation (SD) P a g e | 9
and standard error of the mean (SEM). The results are presented as mean ± SD or mean ± SEM. The normality of the data was assessed using the Shapiro-Wilk and Kolmogorov-Smirnov tests. Parametric statistical tests (one-way ANOVA and independent-samples t-test) were used to compare means and investigate statistical differences for normally distributed data. When the data showed a non-normal distribution, the Kruskal-Wallis test and the Mann-Whitney u-test (non-parametric tests) were used as alternatives for the one-way ANOVA and independent-samples ttest, respectively. The one-sample t-test was used to compare the mean of a normal sample with a ND sample whose mean was considered to be zero. Finally, a probability of p < 0.05 was considered statistically significant.
Results and Discussion
Mass balance method validation
The results Table 1 . More than 90% of the applied HEX D was recovered from the skin surface. In addition, the skin surface recovery for each vehicle was not statistically different from the respective total recovery (one-way ANOVA, p > 0.05) which ranged from 91.36% for the PEG 200 solution to 93.10% for the glycerol solution. Values for skin surface and total recovery were statistically higher than for skin extraction (one-way ANOVA, p < 0.001). Less than 1% of the applied HEX D was delivered into the skin. This is not surprising considering that the molecular weight, the log Do/w at pH = 7.4 and the melting point of HEX D are not ideal for topical drug delivery (Parisi et al., 2015) . In Similarly for HEX H, no permeation was observed after the 48 h in-vitro permeation studies for PG, glycerol and PEG 200 solutions (Table 2) . (Table 1) . Unsurprisingly, there were no significant differences between the skin surface and the total recoveries (one-way ANOVA, p > 0.05) which are significantly higher than the corresponding skin extraction recoveries (one-way ANOVA, p < 0.001). Although the overall topical delivery of HEX D was poor, the amount of active extracted from the skin for PEG 200:TC was significantly higher than values for PG:TC and glycerol:TC (one-way ANOVA, p < 0.01).
As for HEX D most of the HEX H remained on the skin surface (Table 2) Therefore, the higher solubility should result in a lower thermodynamic activity of HEX H in the binary solvent systems compared with HEX D. Ultimately this would result in a reduced driving force for HEX H into the skin despite the more favourable physicochemical properties of HEX H for topical delivery compared with HEX D.
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We hypothesised that the use of TC in combination with PG, glycerol and PEG 200 might enhance the topical delivery of HEX D and HEX H in comparison to delivery in single solvents. Harrison et al. (1996) and Puglia and Bonina (2008) reported long-standing use in pharmaceutical and cosmetic products (Sullivan Jr. et al., 2014) .
TC is also widely used for its enhancing action on the transdermal delivery of active ingredients and for its ability to promote topical delivery via formation of intracutaneous depots (Osborne, 2011) . This last effect was particularly appealing considering that the aim of this work was the topical delivery of HEX D and HEX H.
However, as noted by Osborne (2011) it is difficult to make predictions of the efficacy of TC in enhancing the permeation of active ingredients. The precise mechanism of action of this compound where it does function as a CPE is still not fully understood. We have also recently reported the superior penetration of TC compared with PG and butylene glycol in human skin in vitro where saturated solutions of a different model active were investigated (Hadgraft and Lane, 2016) . (Table 2) .
Binary systems of PG, glycerol and PEG 200 with DMI
In contrast to HEX D, binary solvent systems of DMI with PG, glycerol and PEG 200 delivered HEX H into the skin although the amounts were low, with less than 0.90% of the applied amount recovered ( Table 2 ). The PG:DMI and the PEG 200:DMI systems delivered statistically similar amounts of HEX H into the skin (independent-samples t-test, p > 0.05). However, while no significant difference was found between the former and the glycerol:DMI vehicle (independent-samples t-test, p > 0.05), the latter delivered a significantly higher amount of HEX H into the skin than the glycerol:DMI (50:50) solution (independent-samples t-test, p < 0.01).
Although the DMI systems were not particularly effective in targeting HEX D and HEX H to the skin, differences were observed in the overall topical delivery of the two salts. Significantly higher amounts of HEX H were delivered into the skin from the PG:DMI and glycerol:DMI solutions (one-sample t-test, p < 0.01 and p < 0.05, respectively). However, no differences were found between the solution of HEX H in PEG 200:DMI and the saturated solution of HEX D in the same system (independent-samples t-test, p = 0.051). This last outcome was particularly interesting considering that HEX D had maximal thermodynamic activity in PEG 200:DMI. It may be concluded that for this set of binary systems at least, the use of the dihydrochloride rather than the diisethionate salt is preferred for optimum delivery into the skin.
The amounts of HEX D and HEX H extracted from the skin for the PG solutions were significantly higher than those for the corresponding PG:DMI (50:50)
solutions (one-sample t-test, p < 0.001 and Mann-Whitney u-test, p < 0.01, respectively). The same was observed for the glycerol solutions which, again, delivered more of each active into the skin than the glycerol:DMI vehicle (onesample t-test, p < 0.001 and independent-samples t-test, p < 0.05, respectively). The topical delivery of HEX D from the PEG 200 solution was significantly higher than for the saturated solution of HEX D in PEG 200:DMI (independent-samples t-test, p < 0.05), no differences were found between the same solvent systems containing HEX H (independent-samples t-test, p > 0.05).Contrasting opinions on the efficacy P a g e | 17
of DMI as a CPE are reported and, in some studies, DMI has been used as a control or diluent for other penetration enhancers because it was considered to have no enhancing action (Bennett et al., 1985; Funke et al., 2002) .
Binary systems of PG, glycerol and PEG 200 with 1,2-PENT
No HEX D penetrated through the skin from the PG:1,2-PENT, glycerol:1,2-PENT and PEG 200:1,2-PENT vehicles (Table 1 ). All three systems delivered ~ 1%
of the applied HEX D dose into the skin. As a result, the skin extraction recoveries were statistically lower than the corresponding skin surface and total recoveries (one- (Table 2 ). More than 95% of the active was recovered from the skin surface while less than 1.5% was found inside the membrane. The skin extraction recoveries were thus significantly lower than the corresponding skin surface and total recoveries (one-way ANOVA, p < 0.001) which, in turn, did not show statistical differences (one-way ANOVA, p > 0.05). All binary solvent systems delivered similar amounts of HEX H into the skin and no statistical differences were observed between them (one-way ANOVA, p > 0.05). Actual amounts of active recovered by extraction and measured in receptor compartment also inset (n=5; mean ± SD) P a g e | 22
Interestingly
found to be stable in both PG:PGML and PBS (Parisi et al., 2015) , the low total recovery might be attributed to interaction and/or degradation by skin enzymes. PGML is the monoester of lauric acid with PG and is used in dermal and topical drug delivery as a water-in-oil surfactant, emulsion stabiliser and active ingredient solubiliser and is associated with enhanced penetration of actives (Gattefossé, 2010a; Gattefossé, 2010b) . Neat PGML, incorporated into a silicone based pressure sensitive adhesive, enhanced estradiol permeation through human cadaver epidermis (Irion et al., 1995) . PGML has also been combined with other vehicles and synergistic actions have been demonstrated. Roy et al. (1994) , for instance, showed that the addition of 10% PGML to PG increased buprenorphine flux through human cadaver epidermis by a factor of 7.5 compared with PG alone. In the same study it was also demonstrated that the concomitant inclusion of 15% PGML and 5% water to PG led to a 110-fold increase in the transdermal transport of the hydrochloride salt of buprenorphine. The recent work of Mohammed et al. (2014) highlighted the exceptional effect of PG:PGML (50:50) on the delivery of niacinamide across human skin both in-vitro and in-vivo. In the in-vitro permeation studies, the niacinamide flux from the binary solvent system was 437 times higher than that from neat PG. The in-vivo confocal Raman spectroscopy studies showed that the signal intensity of the stratum corneum depth profile of niacinamide was considerably stronger for the PG:PGML system rather than for PG alone. The grade of PGML used in the present work is reported to contain less than 6% of free saturated fatty acids, the majority being lauric acid (Gattefossé, 2010b) . Saturated fatty acids are well known chemical penetration enhancers and their maximal activity is associated with chain lengths of C9-C12 (Aungst et al., 1986; Aungst, 1989) . A number of publications demonstrated both the efficacy of lauric acid and the impact of its synergy with PG on the transdermal deliveries of actives with disparate physicochemical properties using human skin (Green et al., 1988; Roy et al., 1994) .
Lauric acid has been shown to form ion pairs with cationic actives, thus increasing their hydrophobic nature and enhancing their transport through lipophilic membranes (Green and Hadgraft, 1987; Green et al., 1988; Stott et al., 2001) . The presence of lauric acid may therefore have contributed to the enhancing effect of PGML on the P a g e | 25
topical delivery of HEX D and HEX H. It is also notable that most of the literature has focused on the ability of PGML to enhance transdermal rather than topical delivery of actives.
Conclusions
As we have previously reported, the physicochemical properties of HEX H suggest that this salt is a better candidate for topical delivery than HEX D. Despite a higher melting point, HEX H has a smaller MW and a higher log Do/w at pH = 7. .65 mg/mL, respectively). As a result, the thermodynamic activity of HEX D and HEX H in binary solvent systems containing 1,2-PENT is comparatively low thus affecting the driving force of the systems and, ultimately, reducing the partitioning of the actives into the stratum corneum. IPA is present in 3 of the 10 binary solvent systems which enhanced topical delivery compared with neat solvents; interestingly, while IPA promoted skin uptake of HEX D, no effect was observed for HEX H.
The 6 binary solvent systems containing PGML in combination with PG, glycerol and PEG 200 complete the set of the ten systems which enhanced the topical delivery of HEX D and HEX H with the PG:PGML system clearly outranking the P a g e | 26
other vehicles. As noted, neat PGML is reported to enhance the percutaneous penetration of several active ingredients and synergistic effects have been reported when PGML is combined with hydrophilic enhancers containing hydroxy groups such as PG. Glycerol, which has three hydroxy groups in its chemical structure, and PEG 200, which has two hydroxy groups and numerous ether groups, are hydrophilic solvents. It may thus be hypothesised that as for PG, the combination of glycerol and PEG 200 with PGML may exert a synergistic action on the skin delivery of active ingredients and, in this case, may have contributed to the enhancement of the topical delivery of HEX D and HEX H. The PGML grade used for these investigations contained small percentages of lauric acid which has enhancing effects in its own right and it also acts synergistically with PG. To determine whether an ion-pair mechanism is relevant for this work further experiments are ongoing.
Finally, it is important to note that the mechanisms of action of the enhancers examined in this study remain to be fully elucidated. Even though we have conducted a comprehensive evaluation of two salts of the same active it is clearly not possible to predict that enhancement effects will be achieved depending on the CPEs selected. We believe this further underlines the necessity for fundamental investigations into the fate of excipients and CPEs when applied to the skin. These studies will provide important insights for rational formulation design in the future.
